207 related articles for article (PubMed ID: 11977317)
1. Expression of selected T-cell antigens in the skin infiltration in primary cutaneous T-cell lymphomas.
Wojnowska D; Lecewicz-Toruń B; Chodorowska G; Juszkiewicz-Borowiec M; Skomra D
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():237-42. PubMed ID: 11977317
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
3. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
4. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
[TBL] [Abstract][Full Text] [Related]
5. Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression.
Lindae ML; Abel EA; Hoppe RT; Wood GS
Arch Dermatol; 1988 Mar; 124(3):366-72. PubMed ID: 3257858
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
7. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
8. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
Kelemen K; White CR; Gatter K; Braziel RM; Fan G
Am J Clin Pathol; 2010 Nov; 134(5):739-48. PubMed ID: 20959657
[TBL] [Abstract][Full Text] [Related]
10. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates.
Florell SR; Cessna M; Lundell RB; Boucher KM; Bowen GM; Harris RM; Petersen MJ; Zone JJ; Tripp S; Perkins SL
Am J Clin Pathol; 2006 May; 125(5):727-36. PubMed ID: 16707374
[TBL] [Abstract][Full Text] [Related]
11. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
13. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides.
Michie SA; Abel EA; Hoppe RT; Warnke RA; Wood GS
Am J Pathol; 1990 Dec; 137(6):1447-51. PubMed ID: 2260631
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides with a CD56+ immunophenotype.
Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R
J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
16. The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.
Massone C; Crisman G; Kerl H; Cerroni L
Br J Dermatol; 2008 Sep; 159(4):881-6. PubMed ID: 18644018
[TBL] [Abstract][Full Text] [Related]
17. Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides.
Ortonne N; Buyukbabani N; Delfau-Larue MH; Bagot M; Wechsler J
Mod Pathol; 2003 Sep; 16(9):857-62. PubMed ID: 13679448
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice.
Ormsby A; Bergfeld WF; Tubbs RR; Hsi ED
J Am Acad Dermatol; 2001 Sep; 45(3):405-13. PubMed ID: 11511839
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
20. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
Horst BA; Kasper R; LeBoit PE
Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]